Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Atenza XL 18mg tablets
0404000M0BQADAM
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 27mg tablets
0404000M0BQACAT
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 36mg tablets
0404000M0BQABAN
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
|
Atenza XL 54mg tablets
0404000M0BQAAAR
|
Atenza | Methylphenidate hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.